Suzhou Zelgen Biopharmaceuticals Co Ltd - Class A

SHSE:688266 (China)   Class A
Â¥ 60.98 (-1.76%) Dec 25
At Loss
P/B:
12.39
Market Cap:
Â¥ 16.14B ($ 2.25B)
Enterprise V:
Â¥ 15.15B ($ 2.08B)
Volume:
202.25M
Avg Vol (2M):
2.68M
Trade In:
Volume:
202.25M
At Loss

Business Description

Description
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 2.39
Equity-to-Asset 0.44
Debt-to-Equity 0.71
Debt-to-EBITDA -5.55
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.35
Distress
Grey
Safe
Beneish M-Score -2.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.84
9-Day RSI 31.88
14-Day RSI 39.15
6-1 Month Momentum % 16.86
12-1 Month Momentum % 29.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.95
Quick Ratio 1.83
Cash Ratio 1.68
Days Inventory 1379.77
Days Sales Outstanding 84.68
Days Payable 1383.07

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.3
Shareholder Yield % -1.47
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Suzhou Zelgen Biopharmaceuticals Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 488.45
EPS (TTM) (Â¥) -0.66
Beta 1.39
Volatility % 43.36
14-Day RSI 39.15
14-Day ATR (Â¥) 2.305276
20-Day SMA (Â¥) 66.16
12-1 Month Momentum % 29.24
52-Week Range (Â¥) 33.2 - 79.99
Shares Outstanding (Mil) 264.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Suzhou Zelgen Biopharmaceuticals Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Suzhou Zelgen Biopharmaceuticals Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Suzhou Zelgen Biopharmaceuticals Co Ltd Frequently Asked Questions

What is Suzhou Zelgen Biopharmaceuticals Co Ltd(SHSE:688266)'s stock price today?
The current price of SHSE:688266 is ¥60.98. The 52 week high of SHSE:688266 is ¥79.99 and 52 week low is ¥33.20.
When is next earnings date of Suzhou Zelgen Biopharmaceuticals Co Ltd(SHSE:688266)?
The next earnings date of Suzhou Zelgen Biopharmaceuticals Co Ltd(SHSE:688266) is .
Does Suzhou Zelgen Biopharmaceuticals Co Ltd(SHSE:688266) pay dividends? If so, how much?
Suzhou Zelgen Biopharmaceuticals Co Ltd(SHSE:688266) does not pay dividend.

Press Release

Subject Date
No Press Release